ArticleAmerican journal of public health2010
Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.
Article in American journal of public health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.
- Association Between Depression and Antiretroviral Therapy Use Among People Living with HIV: A Meta-analysis.AIDS and behavior · 2018Pooled it
- Pilot Randomized Controlled Trial of an Intervention to Improve Coping with Intersectional Stigma and Medication Adherence Among HIV-Positive Latinx Sexual Minority Men.AIDS and behavior · 2021Trial
- Religiosity, Social Support, and Ethnic Identity: Exploring "Resilience Resources" for African-American Women Experiencing HIV-Related Stigma.Journal of acquired immune deficiency syndromes (1999) · 2019Trial
- Effects of Lifetime History of Use of Problematic Alcohol on HIV Medication Adherence.Journal of the International Association of Providers of AIDS CareTrial
- Retention in care and antiretroviral therapy adherence among Medicaid beneficiaries with HIV, 2001-2015.AIDS care · 2024Article
- Retention in care and antiretroviral therapy adherence among Medicaid beneficiaries with HIV, 2001-2015.medRxiv : the preprint server for health sciences · 2024Article
- Effects of the ACA on Health Care Coverage for Adults With Substance Use Disorders.Psychiatric services (Washington, D.C.) · 2021Article
- ART uptake and adherence among women who use drugs globally: A scoping review.Drug and alcohol dependence · 2020Article
- The Significance of Taking Antiretroviral Medications for African-Born People Living with HIV and Residing in Minnesota.Pharmacy (Basel, Switzerland) · 2020Article
- HIV-Related Stigma and Viral Suppression Among African-American Women: Exploring the Mediating Roles of Depression and ART Nonadherence.AIDS and behavior · 2019Article
- HIV stigma and viral load among African-American women receiving treatment for HIV.AIDS (London, England) · 2019Article
- Enacted HIV-related stigma and breast-health beliefs and practices among African American women living with HIV: The mediating roles of internalized HIV-related stigma and depressive symptoms.Stigma and health · 2018Article
- Trends in Racial/Ethnic Disparities Among Patients Living with HIV in Texas, 1996 to 2013.Journal of racial and ethnic health disparities · 2018Article
- A Critical Review and Commentary on the Challenges in Engaging HIV-Infected Latinos in the Continuum of HIV Care.AIDS and behavior · 2018Review
- Article
- Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.Open forum infectious diseases · 2017Article
- Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.Journal of acquired immune deficiency syndromes (1999) · 2016Article
- Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States.Drug and alcohol dependence · 2014Article
- Article
- Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.Journal of acquired immune deficiency syndromes (1999) · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
objectivesWe examined racial/ethnic disparities in highly active antiretroviral therapy (HAART) use and whether differences are moderated by substance use or insurance status, using data from the Women's Interagency HIV Study (WIHS).
methodsLogistic regression examined HAART use in a longitudinal cohort of women for whom HAART was clinically indicated in 2005 (N = 1354).
resultsApproximately 3 of every 10 eligible women reported not taking HAART. African American and Hispanic women were less likely than were White women to use HAART. After we adjusted for potential confounders, the higher likelihood of not using HAART persisted for African American but not for Hispanic women. Uninsured and privately insured women, regardless of race/ethnicity, were less likely than were Medicaid enrollees to use HAART. Although alcohol use was related to HAART nonuse, illicit drug use was not.
conclusionsThese findings suggest that expanding and improving insurance coverage should increase access to antiretroviral therapy across racial/ethnic groups, but it is not likely to eliminate the disparity in use of HAART between African American and White women with HIV/AIDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.